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Following the first transcatheter aortic valve implantation (TAVI) performed by Cribier and colleagues in 2002 [1] , this procedure has evolved considerably to the point where it is now on the verge of posing a viable treatment option amongst intermediate surgical-risk patients with symptomatic severe aortic stenosis [2] . In the early days of TAVIs' evolution, cerebrovascular events were considered as the iceberg standing in the way of the "TAVI Titanic" [3] . Recent randomized trials reflecting improved patients' selection, increased operators' experience, and iterated devices have somewhat dissipated those fears, with a similar incidence of cerebrovascular events already demonstrated between TAVI and surgical aortic valve replacement [2, 4] . However, these clinically overt events seem to be the tip of the iceberg, with silent cerebral micro-embolization and its potential cognitive consequences, lurking beneath the surface [5] . The emergence of embolic protection devices (EPDs), along with the trend towards treating lower surgical-risk patients, shed further light on these specific issues, which are increasingly recognized as a surrogate burden of the ischemic cerebral insult imparted during TAVI [6, 7] .
In the setting of surgical aortic valve replacement, a recent review reported rates of 50 to 70% of cognitive decline (CD) within a week of cardiac surgery whereas 10 to 20% of patients exhibited persistent CD at 1 year [8] . A few seminal studies attempted to navigate the deep and dark waters of cognitive evaluation early post-TAVI, mainly demonstrating preserved, and even improved, cognition [5] . However, most of these studies focused on global cognition or memory during a short-term follow-up period without serial evaluations. Moreover, changes in cognitive function were assessed by performing formal statistical tests on the mean or median cognitive scores in the setting of small sample-size, therefore implying the risk of type II error. By contrast, recent studies evaluating the use of EPD suggested that rates of early CD, on the basis of the Montréal Cognitive Assessment (MoCA) measurement, may be as high as 50 to 72% at day 2 post-TAVI and 37 to 55% at discharge [6, 7] .
Interestingly, the use of EPDs seemed to mitigate this deleterious effect on cognition. Nonetheless, these studies defined CD as a drop of at least 1 point in the MoCA score, thus failing to properly take into account the variability of changes across tests, which depends on the stability and reliability of the assessment tool [9, 10] . In other words, in the worst case scenario, these findings only reflect random variability.
To avoid this pitfall of cognitive evaluation, some studies used specific methods to account for this inherent variability [5, 11, 12] . In the first of its type, Ghanem et al. [11] used tests allowing an integrative measure of global cognition through measurements of several cognitive domains. However, the standard deviation method used in these studies may be prone to overclassifying CD compared with more stringent methods such as practice-corrected reliable change index (RCI) or regression based methods [10] . Besides, both the MMSE and RBANS lack sensitivity in the detection of mild cognitive impairment. By contrast, the MoCA, albeit less commonly performed than the MMSE, demonstrated a greater sensitivity in the detection of subtle cognitive changes, due to the inclusion of a more comprehensive evaluation of executive functions which are predominantly impaired in vascular cognitive impairment [13] .
Recently, we reported the cognitive trajectory of 51 TAVR recipients during a 1 year followup period, using the MoCA and practice-corrected RCI to define cognitive changes [5] . On the basis of the RCI of MoCA score, 4 patients (7.8%) presented with 30-day CD, which persisted at 1 year in 1 patient (2.0%). Overall, 11.8% of patients exhibited CD at 1 year post-TAVI. Using 5 specific tests for some complex executive functions, we demonstrated that a quarter of TAVI recipients experienced a deterioration in at least one of these tests at 1 month post-TAVI, which was transient in 60% of these patients and sustained in 40 % of them (10% of the global cohort). Interestingly, we failed to demonstrate a meaningful association between cognitive changes and subsequent quality-of-life or functional status. Overall, the available evidences suggest that mid-term CD affects ≈10 to 15% of TAVI recipients. Early CD (i.e. the most likely to result from the procedure itself) occurs in 2 to 10% of patients when considering global cognition, may affect 25% of them when specific cognitive domains are evaluated, and seems to persist in 25 to 50% of these patients.
On the contrary, an early and sustained cognitive improvement post-TAVI has also been demonstrated in a sizeable proportion of TAVI recipients [5, 6, 12] , ranging from 8 to 38% depending on the assessment tool, timing of the evaluation and methods used to define cognitive changes. This improvement seems more likely amongst patients cognitively-impaired at baseline [5, 12] . the occurrence of CD following surgical aortic valve replacement [14] ; a finding that has been recently reproduced in only one small study in the setting of TAVI, demonstrating a moderate but significant correlation between CD and the number and volume of new cerebral lesions on diffusion-weighted magnetic resonance imaging [15] . Identifying predictors of cognitive changes and evaluating neuroprotective strategies in high-risk subgroups are other areas of major interest. Finally, of particular importance is the impact of cognitive changes on TAVI recipients' quality-of-life and functional status; largely unknown to date. There is much still to be discovered in the fascinating land of post-TAVI cognition, and it is safe to say that this incredible journey is thus far from drawing to an end…
